Home›Stock Screener›Coral Laboratories›Financial Statements

Coral Laboratories Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Coral Laboratories (CORALAB) reported revenue ₹86 Cr, net profit ₹17 Cr and EPS ₹45.85, with a net profit margin of 19.8% and ROE of 8.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse CORALAB shareholding pattern to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 19.77% 2026 data
EBITDA Margin 17.44% 2026 data
Operating Margin 18.00% 2026 data
Return on Assets 7.05% 2026 data
Return on Equity 8.13% 2026 data

Balance Sheet Ratios

Current Ratio 44.25 2026 data
Equity Ratio 86.72% 2026 data
Asset Turnover 0.36 2026 data

CORALAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

CORALAB YoY (March 2025 vs March 2026) — revenue -30.6%, net profit -29.2%, EBITDA -57.1%, expenses -20.2%. Also explore Coral Laboratories share price performance to track price trends across different timeframes.

Revenue Growth
-30.6%
Year-over-Year
Net Profit Growth
-29.2%
Year-over-Year
EBITDA Growth
-57.1%
Year-over-Year
Expense Growth
-20.2%
Year-over-Year
Assets Growth
+4.8%
Year-over-Year
Equity Growth
+4.0%
Year-over-Year
Operating Cash Flow Growth
+83.3%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year

CORALAB Income Statement — Revenue, EBITDA & Net Profit

Coral Laboratories revenue ₹86 Cr, EBITDA ₹15 Cr, net profit ₹17 Cr, EPS ₹45.85 (2026) — net profit margin 19.8%. For live price, earnings ratios and company overview, see CORALAB screener.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 86 124 90 85 80 100 77 96 97 99 80 62
Expenses 71 89 67 74 67 81 65 79 77 72 61 47
EBITDA 15 35 23 11 13 20 11 17 20 27 19 15
Operating Profit Margin % 18.00% 23.00% 19.00% 5.00% 11.00% 16.00% 8.00% 13.00% 16.00% 24.00% 21.00% 21.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 23 33 21 8 12 18 9 16 18 25 17 12
Tax 6 8 5 2 3 4 2 5 6 8 5 3
Net Profit 17 24 16 6 9 14 7 10 12 16 12 10
Earnings Per Share (₹) 45.85 67.61 44.19 18.04 25.32 37.94 19.96 28.60 34.84 45.61 34.70 26.79

CORALAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

CORALAB total assets ₹241 Cr, total equity ₹209 Cr, total liabilities ₹ Cr (2026) — ROE 8.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 241 230 206 174 190 168 144 136 140 131 90 72
Current Assets 177 177 154 124 131 129 96 84 72 74 65 50
Fixed Assets 44 23 24 25 24 21 23 23 22 18 18 19
Capital Work in Progress 0 3 0 0 2 1 0 0 0 0 0 0
Investments 21 52 50 41 46 33 25 28 45 39 0 0
Other Assets 0 152 132 108 118 112 97 85 73 74 71 54
LIABILITIES
Total Liabilities
Current Liabilities 4 3 3 8 8 3 4 4 4 4 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 209 201 178 155 156 137 116 114 116 109 70 59
Share Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 206 198 174 151 153 133 112 110 113 106 67 56

CORALAB Cash Flow Statement — Operating, Investing & Financing

Coral Laboratories operating cash flow ₹-1 Cr, investing ₹0 Cr, financing ₹3 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -1 -6 13 6 1 -4 -1 14 11 5 0
Investing Activities 0 1 -3 -6 0 -2 3 -13 -10 -3 -1
Financing Activities 3 0 -6 0 0 4 -1 -3 1 0 0
Net Cash Flow 1 -4 4 0 1 -2 1 -2 2 2 0